Exhibitor Puma Biotechnology 11-6 - Scripps CME Connection
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict - Los Angeles Business Journal
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
Puma Biotechnology, Inc. | LinkedIn
Puma Biotech plunges on drug side effects
Puma Biotechnology reports interim SUMMIT results for neratinib | Drug Discovery News
Can Puma Biotechnology Inc (PBYI) Stock Rise to the Top of Healthcare Sector Tuesday?
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Puma Biotechnology
Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Puma Bio Bulls Win Monday's FDA Neratinib Review, Ahead of Wednesday's Advisory Panel Vote - TheStreet
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma
Puma Biotechnology
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com
Puma Biotechnology
Puma Biotechnology, Inc.
Articles with Puma Biotechnology
